A citation-based method for searching scientific literature

Carlo Visco, Ilaria Tanasi, Francesca Maria Quaglia, Isacco Ferrarini, Costanza Fraenza, Mauro Krampera. Cancers (Basel) 2020
Times Cited: 16







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
50

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
43

Oncogenically active MYD88 mutations in human lymphoma.
Vu N Ngo, Ryan M Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, Weihong Xu, Yandan Yang, Hong Zhao,[...]. Nature 2011
31

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
713
25

Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova,[...]. Blood 2016
305
25

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.
Naema Nayyar, Michael D White, Corey M Gill, Matthew Lastrapes, Mia Bertalan, Alexander Kaplan, Megan R D'Andrea, Ivanna Bihun, Andrew Kaneb, Jorg Dietrich,[...]. Blood Adv 2019
43
25

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
25

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen McPhail, Yan W Asmann, Jan Egan, Jackline Ayres da Silva, David Schiff, M Beatriz Lopes, Paul A Decker,[...]. Clin Cancer Res 2015
125
18

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
18

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Stuart E Lacy, Sharon L Barrans, Philip A Beer, Daniel Painter, Alexandra G Smith, Eve Roman, Susanna L Cooke, Camilo Ruiz, Paul Glover, Suzan J L Van Hoppe,[...]. Blood 2020
129
18

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
18

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Joost S Vermaat, Sebastiaan F Somers, Liesbeth C de Wreede, Willem Kraan, Ruben A L de Groen, Anne M R Schrader, Emile D Kerver, Cornelis G Scheepstra, Henriëtte Berenschot, Wendy Deenik,[...]. Haematologica 2020
35
18

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
18

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
R Eric Davis, Vu N Ngo, Georg Lenz, Pavel Tolar, Ryan M Young, Paul B Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang,[...]. Nature 2010
18

Diagnosis of intraocular lymphoma by flow cytometry.
J L Davis, A L Viciana, P Ruiz. Am J Ophthalmol 1997
90
12

Cytokine and molecular analyses of intraocular lymphoma.
Kouichi Ohta, Kenji Sano, Hiroki Imai, Takanobu Kikuchi. Ocul Immunol Inflamm 2009
28
12

Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chi-Chao Chan, James L Rubenstein, Sarah E Coupland, Janet L Davis, J William Harbour, Patrick B Johnston, Nathalie Cassoux, Valerie Touitou, Justine R Smith, Tracy T Batchelor,[...]. Oncologist 2011
255
12

Epidemiology of primary CNS lymphoma.
M Schabet. J Neurooncol 1999
163
12


Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
L M Weiss, R A Warnke, J Sklar, M L Cleary. N Engl J Med 1987
652
12


Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.
Sarah E Coupland, Nikolaos E Bechrakis, Gerasimos Anastassiou, Andreas M H Foerster, Arnd Heiligenhaus, Uwe Pleyer, Michael Hummel, Harald Stein. Graefes Arch Clin Exp Ophthalmol 2003
96
12

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
12

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
W Kraan, H M Horlings, M van Keimpema, E J M Schilder-Tol, M E C M Oud, C Scheepstra, P M Kluin, M J Kersten, M Spaargaren, S T Pals. Blood Cancer J 2013
134
12

Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Andi K Cani, Daniel H Hovelson, Hakan Demirci, Mark W Johnson, Scott A Tomlins, Rajesh C Rao. Oncotarget 2017
53
12

Interleukin-10 in the vitreous of patients with primary intraocular lymphoma.
C C Chan, S M Whitcup, D Solomon, R B Nussenblatt. Am J Ophthalmol 1995
133
12

Understanding intraocular lymphomas.
Sarah E Coupland, Bertil Damato. Clin Exp Ophthalmol 2008
189
12

Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
M Montesinos-Rongen, A Brunn, S Bentink, K Basso, W K Lim, W Klapper, C Schaller, G Reifenberger, J Rubenstein, O D Wiestler,[...]. Leukemia 2008
111
12

Ocular involvement in patients with primary CNS lymphoma.
Jung Taeck Hong, Ju Byung Chae, Joo Yong Lee, June-Gone Kim, Young Hee Yoon. J Neurooncol 2011
31
12

ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?
Grzegorz S Nowakowski, Myron S Czuczman. Am Soc Clin Oncol Educ Book 2015
71
12


Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah S Tang, Carl Campos, Derrek Schartz, Paolo Codega, Donna Nichol, Owen Clark, Wan-Ying Hsieh,[...]. Cancer Discov 2017
207
12

Diagnosis of intraocular lymphoma by polymerase chain reaction.
N Katai, S Kuroiwa, K Fujimori, N Yoshimura. Graefes Arch Clin Exp Ophthalmol 1997
28
12

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
J J M van Dongen, A W Langerak, M Brüggemann, P A S Evans, M Hummel, F L Lavender, E Delabesse, F Davi, E Schuuring, R García-Sanz,[...]. Leukemia 2003
12

Diagnostic testing of vitrectomy specimens.
Janet L Davis, Daniel M Miller, Phillip Ruiz. Am J Ophthalmol 2005
122
12

Primary lymphoma of the central nervous system: just DLBCL or not?
Manuel Montesinos-Rongen, Reiner Siebert, Martina Deckert. Blood 2009
54
12

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
S A Grimm, J S Pulido, K Jahnke, D Schiff, A J Hall, T N Shenkier, T Siegal, N D Doolittle, T Batchelor, U Herrlinger,[...]. Ann Oncol 2007
160
12

Biopsy techniques and yields in diagnosing primary intraocular lymphoma.
John A Gonzales, Chi-Chao Chan. Int Ophthalmol 2007
67
12

MyD88: a central player in innate immune signaling.
Jacques Deguine, Gregory M Barton. F1000Prime Rep 2014
294
12

Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
Yujuan Wang, Defen Shen, Vinson M Wang, H Nida Sen, Chi-Chao Chan. Int J Mol Sci 2011
65
12

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
T Nakamura, K Tateishi, T Niwa, Y Matsushita, K Tamura, M Kinoshita, K Tanaka, S Fukushima, H Takami, H Arita,[...]. Neuropathol Appl Neurobiol 2016
112
12

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, Brigitte C Widemann, John A Butman, Roland Schmitz, Yandan Yang, Diane E Cole, Christopher Melani, Christine S Higham,[...]. Cancer Cell 2017
288
12

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
K Karube, A Enjuanes, I Dlouhy, P Jares, D Martin-Garcia, F Nadeu, G R Ordóñez, J Rovira, G Clot, C Royo,[...]. Leukemia 2018
98
12

Primary CNS Lymphoma.
Christian Grommes, Lisa M DeAngelis. J Clin Oncol 2017
243
12

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
12

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.
Joel C Wight, Geoffrey Chong, Andrew P Grigg, Eliza A Hawkes. Blood Rev 2018
28
12

Genetics of diffuse large B-cell lymphoma.
Laura Pasqualucci, Riccardo Dalla-Favera. Blood 2018
127
12

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Leonard Jeff Harris, Kruti Patel, Michael Martin. Int J Mol Sci 2020
14
14

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.
Nitin Jain, Wendy Stock, Amer Zeidan, Ehab Atallah, James McCloskey, Leonard Heffner, Benjamin Tomlinson, Bhavana Bhatnagar, Jay Feingold, David Ungar,[...]. Blood Adv 2020
24
12

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
Gilles Salles, Monika Długosz-Danecka, Hervé Ghesquières, Wojciech Jurczak. Expert Opin Biol Ther 2021
11
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.